Nu Skin Enterprises’s Earnings Outlook

Nu Skin Enterprises (NYSE:NUS) is set to give its latest quarterly earnings report on Wednesday, 2024-02-14. Here’s what…

Nu Skin Enterprises (NYSE:NUS) is set to give its latest quarterly earnings report on Wednesday, 2024-02-14. Here’s what investors need to know before the announcement.

Analysts estimate that Nu Skin Enterprises will report an earnings per share (EPS) of $0.28.

Nu Skin Enterprises bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company missed EPS by $0.06, which was followed by a 9.45% drop in the share price the next day.

Here’s a look at Nu Skin Enterprises’s past performance and the resulting price change:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate 0.62 0.53 0.33 0.53
EPS Actual 0.56 0.54 0.37 0.89
Price Change % -9.45% -7.63% -3.32% -4.21%

eps graph

Stock Performance

Shares of Nu Skin Enterprises were trading at $18.72 as of February 09. Over the last 52-week period, shares are down 58.75%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

To track all earnings releases for Nu Skin Enterprises visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Sandvik Earnings Preview

Sandvik (OTC:SDVKY) is set to give its latest quarterly earnings report on Monday, 2022-10-17. Here's what investors need to know before the announcement. Analysts estimate that Sandvik will report an earnings per share (EPS) of $0.21.

SDVKY

Read More

This Cannabis Co. Expects Significant Growth Once Ohio’s Retail Market Launches, Reports Slight YoY Decrease In 2023 Revenue

Vext Science, Inc., which runs vertical cannabis operations in Arizona and Ohio, reported on Friday its financial results for the period ended Dec. 31, 2023. Revenue for 2023 slightly dropped year-over-year to $34.8 million from $35.4 million in 2022. Fourth quarter revenue grew year-year to $8.4 million, from $8.1 million in the prior year's quarter.

CSE:VEXT